Discovery of novel non-cytotoxic salicylhydrazide containing HIV-1 integrase inhibitors.
Laith Q Al-Mawsawi, Raveendra Dayam, Laleh Taheri, Myriam Witvrouw, Zeger Debyser, Nouri Neamati
Index: Bioorg. Med. Chem. Lett. 17(23) , 6472-5, (2007)
Full Text: HTML
Abstract
The previously discovered salicylhydrazide class of compounds displayed potent HIV-1 integrase (IN) inhibitory activity. The development of this class of compounds as antiretroviral agents was halted due to cytotoxicity in the nanomolar to sub-micromolar range. We identified a novel class of non-cytotoxic hydrazide IN inhibitors utilizing the minimally required salicylhydrazide substructure as a template in a small-molecule database search. The novel hydrazides displayed low micromolar IN inhibitory activity and are several hundred-fold less cytotoxic than previously disclosed salicylhydrazide IN inhibitors.
Related Compounds
Related Articles:
2015-01-01
[Bioinorg. Chem. Appl. 2015 , 126023, (2015)]
Salicylidene salicylhydrazide, a selective inhibitor of beta 1-containing GABAA receptors.
2004-05-01
[Br. J. Pharmacol. 142 , 97-106 , (2004)]
2009-03-01
[Curr. Cancer Drug Targets 9(2) , 189-201, (2009)]
The emitting species formed by the oxidation of hydrazides with hypohalites or N-halosuccinimides.
2004-01-01
[Luminescence 19(4) , 205-8, (2004)]